2291 — Lepu Scientech Medical Technology Shanghai Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Market Cap
HK$8.95bn
Enterprise Value
HK$7.75bn
Revenue
CNY471.64m

Annual income statement for Lepu Scientech Medical Technology Shanghai Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	CAS	CAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	148	223	248	327	472
Cost of Revenue
Gross Profit	133	198	220	289	424
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	71.7	146	249	154	186
Operating Profit	76.5	76.4	-1.73	172	286
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	76.7	66	-15	173	286
Provision for Income Taxes
Net Income After Taxes	68.8	58.7	-19.8	151	246
Net Income Before Extraordinary Items
Net Income	68.8	58.7	-19.8	151	246
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	68.8	58.7	-19.8	151	246
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.198	0.253	-0.02	0.437	0.708
Dividends per Share